Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #9, September 2002
State Judge Grants Class Certification to Individuals Who Suffered Oxycontin Addiction and Withdrawal
A lawsuit filed on behalf of Ohio residents who suffered from addiction and withdrawal symptoms associated with the prescription painkiller Oxycontin has been granted class certification by a state judge.
A putative class action filed by the parents and guardians of children who were allegedly injured as the result Pfizer's experimental administration of Trovan is better suited for litigation in Nigeria, a federal judge ruled.
The manufacturers of the weight loss drug Meridia filed a notice to remove a products liability case to federal court claiming that a Louisiana health clinic was fraudulently joined to defeat diversity jurisdiction.
Three Florida women filed a statewide class action against Metabolife International, Inc., claiming that the supplement manufacturer failed to adequately warn consumers and physicians regarding the potential health hazards associated with Metabolife 356.
The widow of a professional indoor football player who collapsed last year after a gam has filed a lawsuit against the manufacturers of Up Your Gas sports supplements and Red Bull energy drink claiming that the products were defective in design and caused
The manufacturers of the diabetes drug Rezulin responded to the claims of a products liability suit filed on behalf of a woman whose death while participating in the Diabetes Prevention Program study was allegedly caused by the drug.
The FDA has requested that a federal judge reject a recent request for a preliminary injunction to stop Paxil manufacturer GlaxoSmithKline from airing ads that claim the drug is habit forming because it is preempted by federal law and the agency has previ
A federal judge denied motions to remand in multiple Fen-phen product liability actions on grounds that the plaintiffs fraudulently joined pharmacies, sales representatives and physicians in an effort to defeat diversity jurisdiction.
The makers of Prempro has removed a case involving an Illinois woman who claims that she developed lumps in her breast as a result of ingesting Prempro.
Two Arkansas women filed a statewide class action suit against the manufacturer of Prempro seeking restitution and reimbursement of costs for the purchase of the hormone replacement therapy, attorneys fees and the establishment of a medical monitoring pro